[18F]FDG at [2] mCi - Non-Human

PETNET Pharmaceuticals Inc. has been awarded a contract by the University of Virginia to supply radiopharmaceutical products. The contract, designated A207_PO-0101975-V3, was executed on September 19, 2026, and covers delivery of [18F]FDG (fluorodeoxyglucose F-18) at a concentration of 2 millicuries in non-human formulation. The line item is priced at a unit rate of $1 per unit with delivery to the University of Virginia as the designated buyer.

The contract involves provision of a positron emission tomography (PET) imaging agent utilized in diagnostic nuclear medicine applications for non-human use. While specific contract values, cumulative amounts, and detailed period of performance terms are not provided in the available documentation, the award represents the University of Virginia's procurement of radiopharmaceutical products from PETNET Pharmaceuticals Inc., a supplier specializing in PET imaging pharmaceuticals. The award is recorded in Virginia's state contracting system.